The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide)

This publication has 22 references indexed in Scilit:

• Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in walker cells
  Biochemical Pharmacology, 1989
• The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
  Biochemical Pharmacology, 1988
• A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells
  Biochemical Pharmacology, 1988
• Human DT-diaphorase, a potential cancer protecting enzyme. Its purification from abdominal adipose tissue
  Cancer Letters, 1988
• DT-diaphorase in morbidly obese patients
  Cancer Letters, 1987
• CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
  Biochemical and Biophysical Research Communications, 1986
• CB 1954 revisited
  Cancer Chemotherapy and Pharmacology, 1986
• Use of quinones in brain‐tumor therapy: Preliminary results of preclinical laboratory investigations
  Journal of Toxicology and Environmental Health, 1985
• The use of the D-T diaphorase for the detection of foci of early neoplastic transformation in rat liver
  Cancer Letters, 1978
• 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256
  Biochemical Pharmacology, 1969